Subcutaneous Injection Market

A subcutaneous injection is administered as a bolus into the subcutis, the layer of skin directly below the dermis and epidermis, collectively referred to as the cutis. Subcutaneous injections are highly effective in administering vaccines and medications such as insulin, morphine, diacetylmorphine and goserelin. Subcutaneous, as opposed to intravenous, injection of recreational drugs is referred to as "skin popping". Subcutaneous administration may be abbreviated as SC, SQ, sub-cu, sub-Q, SubQ, or subcut. Subcut is the preferred abbreviation for patient safety.

Subcutaneous Injection Market contains market size and forecasts of Subcutaneous Injection in Global, including the following market information:

• Global Subcutaneous Injection Market Revenue, 2017-2022, 2023-2028, ($ millions)
• Global top five companies in 2021 (%)

The global Subcutaneous Injection market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Subcutaneous Injection Equipment Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Subcutaneous Injection include Becton Dickinson, Daiichi Sankyo, Sanofi, Roche, GSK, Eli Lilly, Asahi Kasei Pharma, Takeda Pharmaceutical and Antares Pharma, Inc., etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Subcutaneous Injection companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Subcutaneous Injection Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Subcutaneous Injection Market Segment Percentages, by Type, 2021 (%)

• Subcutaneous Injection Equipment
• Subcutaneous Injection Drug
• Others

Global Subcutaneous Injection Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Subcutaneous Injection Market Segment Percentages, by Application, 2021 (%)

• Hospital
• Clinic
• Laboratory
• Others

Global Subcutaneous Injection Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Subcutaneous Injection Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

• Key companies Subcutaneous Injection revenues in global market, 2017-2022 (estimated), ($ millions)
• Key companies Subcutaneous Injection revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Becton Dickinson
• Daiichi Sankyo
• Sanofi
• Roche
• GSK
• Eli Lilly
• Asahi Kasei Pharma
• Takeda Pharmaceutical
• Antares Pharma, Inc.
• Eisai Co. Ltd
• Chugai Pharmaceutical
• Endo International
• PenJet Corporation
• Aspen Medical Group